Genmab A (GMAB) Shares Outstanding (2018 - 2026)

Genmab A (GMAB) has reported Shares Outstanding (Entity) for 6 consecutive years, with $64.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Entity) fell 2.94% year-over-year to $64.2 million; the trailing twelve-month figure through Dec 2025 stood at $64.2 million (down 2.94% YoY), and the FY2025 full-year result was $64.2 million, down 2.94% from the prior year.
• Shares Outstanding (Entity) retreated to $64.2 million in Q4 2025 per GMAB's latest filing, from $66.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $66.2 million in Q4 2024 and bottomed at $64.2 million in Q4 2025.
• Historically, Shares Outstanding (Entity) has averaged $65.6 million across 4 years, with a median of $66.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) increased 0.17% in 2023, then retreated 2.94% in 2025.
• Over 4 years, Shares Outstanding (Entity) stood at $66.0 million in 2022, then gained by 0.17% to $66.1 million in 2023, then rose by 0.17% to $66.2 million in 2024, then fell by 2.94% to $64.2 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $64.2 million, $66.2 million, and $66.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.